TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/17/23 10:06 | 10/13/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S | -5 | 15.10 | 0 | 0 | -1 | 27 | D | ||||||||||||||
10/12/23 11:25 | 10/11/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S | -30 | 15.69 | 0 | -2 | -7 | 26 | D | ||||||||||||||
12/28/21 17:41 | 12/23/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | M.d | 20 | 31.35 | 0 | 1 | 3 | 21 | D | ||||||||||||||
12/28/21 17:41 | 12/23/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S.d | -29 | 44.91 | 0 | -1 | -3 | 21 | D | ||||||||||||||
9/30/21 18:10 | 9/30/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | M.d | 324 | 20.23 | 0 | 16 | 400 | 20 | D | ||||||||||||||
9/30/21 18:10 | 9/30/21 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | S.d | -699 | 43.72 | 0 | -16 | -44 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |